# CITALOPRAM

NDC: 59651-964
Generic name: CITALOPRAM
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260313

FDA application: ANDA219985

## Active ingredients

- CITALOPRAM HYDROBROMIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-964"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-964
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80af8ae8-c106-4895-bab3-0579b41f1e75